LL-37 is a synthetic version of a naturally occurring human antimicrobial peptide known as cathelicidin. It plays a role in the innate immune system and has been studied for its potential involvement in host defense, inflammatory signaling, and tissue repair processes. As part of the body’s first-line immune response, LL-37 is known to interact with microbial membranes and immune regulatory pathways in research settings.

Preclinical studies suggest that LL-37 may influence immune cell recruitment, cytokine modulation, and antimicrobial activity against a broad range of pathogens in laboratory models. These mechanisms are believed to contribute to its observed effects in experimental studies examining wound healing, inflammatory balance, and epithelial barrier function. Researchers have also explored its role in promoting angiogenesis and supporting tissue remodeling under controlled conditions.

Beyond its antimicrobial properties, LL-37 has been investigated for its potential influence on immune signaling pathways, biofilm disruption, and regenerative responses in skin and mucosal tissues. Ongoing research continues to evaluate its impact on innate immunity, inflammatory regulation, and tissue repair signaling.